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Abstract
Following the treads of our previous works on the unveiling of bioactive peptides encrypted
in plant proteins from diverse species, the present manuscript reports the occurrence of four
proof-of-concept intragenic antimicrobial peptides in human proteins, named Hs IAPs.
These IAPs were prospected using the software Kamal, synthesized by solid phase chemis-
try, and had their interactions with model phospholipid vesicles investigated by differential
scanning calorimetry and circular dichroism. Their antimicrobial activity against bacteria,
yeasts and filamentous fungi was determined, along with their cytotoxicity towards erythro-
cytes. Our data demonstrates that Hs IAPs are capable to bind model membranes while
attaining α-helical structure, and to inhibit the growth of microorganisms at concentrations
as low as 1μM. Hs02, a novel sixteen residue long internal peptide (KWAVRIIRKFIKGFIS-
NH2) derived from the unconventional myosin 1h protein, was further investigated in its
capacity to inhibit lipopolysaccharide-induced release of TNF-α in murine macrophages.
Hs02 presented potent anti-inflammatory activity, inhibiting the release of TNF-α in LPS-
primed cells at the lowest assayed concentration, 0.1 μM. A three-dimensional solution
structure of Hs02 bound to DPC micelles was determined by Nuclear Magnetic Resonance.
Our work exemplifies how the human genome can be mined for molecules with biotechno-
logical potential in human health and demonstrates that IAPs are actual alternatives to anti-
microbial peptides as pharmaceutical agents or in their many other putative applications.
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Introduction
Sometimes, Art may offer better ways than Hard Sciences to find truth and understand reality.
The Shakespearian remark "Let every eye negotiate for itself and trust no agent” (W. Shake-
speare—Much Ado About Nothing. Act 2, scene 1) is a fair example of that, if one is willing to
consider some aspects of our present knowledge on protein structure, function and dynamics.
Proteins can be seen and studied under several different “eyes”. In brief, just some of them:
a) simply as a linear biopolymer, product of the translation of RNA molecules by ribosomes in
the cytoplasm; b) as unique sequences of covalently linked amino acid residues that serve as
substrate for enzymes that catalyze various post-translation modifications; c) as a set of peptide
building blocks, secondary structures, domains that are determinant to their final tridimen-
sional folding and mature topology; d) or as molecules exposed to large—occasionally dra-
matic—internal motions and conformational changes induced by solvents, small ligands,
proteins and other macromolecules in order to perform their biological functions under cer-
tain physicochemical conditions.
For more than a decade our research group has decided to systematically “see” proteins as
sources of encrypted bioactive peptides [1]. Initially, the rationale behind this approach was
inspired by the fact that several peptide sequences were identified and reported as free frag-
ments under specific physiologic conditions, structurally independent and autonomous bioac-
tive entities derived from their native parent-proteins. Caseins, hemoglobins, interleukins,
among others, are known to host a variety of these fragments showing in vivo biological func-
tions markedly different from their much larger, intact, mature polypeptide chain donors [2–
5]. In the course of time, our work progressively demonstrated that this phenomenon could be
observed in a wider range of proteins with little or no significant evolutionary relation to the
previous ones [6–8]. Moreover, similarly to some protein folding methodological studies that
“sees” the polypeptide chain as an assembly of particular sub-sets of smaller fragments order-
able in a hierarchical process to yield the final protein architecture, such as: building blocks
(microdomains), hydrophobic folding units (subdomains), protein domain, protein fold (mul-
tidomains) and quaternary structure [9–14], we have also located inside a number of protein
primary structures, shorter amino acid sequences active against pathogenic microorganisms,
potent opioids and hypotensive agents [6,7].
The present work represents an additional step towards a broader evaluation of our prime
hypothesis by searching for different biological functions—yet to be revealed using the present
approach—and, at the same time to challenge our system with different examples that could
reinforce and/or improve our leading searching tool, an in-house developed software named
Kamal. Kamal was used in proof-of-concept publications [6,7] and was recently submitted for
publication and software distribution to the scientific community. In this opportunity, we
report the uncovering as well as the biochemical and biophysical evaluations of four new rep-
resentative peptides derived from the internal sequences of human proteins, called Hs IAPs, or
Homo sapiens Intragenic Antimicrobial Peptides. Human cells express a variety of antimicro-
bial peptides (AMPs) to hinder the proliferation of opportunistic bacteria, yeasts and viruses
[15]. These so-called Host Defense Peptides (HDPs) have direct antimicrobial activity and
orchestrate, in a complex and often uncontrolled manner, the immune system in case of injury
[16–20]. Some of these molecules, such as the cathelicidin LL-37, have also been tested as anti-
microbials for topical application in polymicrobial infected wounds [21,22]. It is our prime
hypothesis that human proteins are source material for encrypted peptides with potent and
broad antimicrobial activity as well as immunomodulatory potential, and therefore can be
considered alternatives to HDPs in various applications, such as topical pharmaceutical
agents.
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Unlike our previous works, here we demonstrate that the novel Hs IAPs not only disturb
the main phase transition of model membranes, fold into amphiphilic α-helical segments
upon binding to model membranes and display distinct antimicrobial activities against Gram-
positive, and -negative bacteria as well as yeasts and filamentous fungi, but also one of these
IAPs—Hs02 (KWAVRIIRKFIKGFIS-NH2)—derived from the unconventional myosin 1h
protein (NP_001094891.3), is a potential inhibitor of lipopolysaccharide-induced release of
pro-inflammatory mediators in murine macrophages. In addition to that, secondary structure
predictions by circular dichroism experiments and a complete 1H NMR structure of Hs02
bound to phospholipid micelles are presented.
Lastly, fine-tuned with the opening Shakespearian quote, we hope that to the reader’s ana-
lytical “eye”, our results alone may stand up above other aspects as the most trustful part of this
manuscript.
Results
Filtering the human genome for encrypted IAPs
Nearly 160.000 Homo sapiens proteins were downloaded in .FASTA format from the Uni-
protKB website and submitted to the software Kamal v2.0. Based in the Kamal filtering proce-
dures described in the material and methods section, 1383, 312 and 48 unique putative IAPs
were found for the polar angles of θ = 192˚, 160˚ and 128˚, which derived from 349, 92, and 36
proteins, respectively. Four putative IAPs were selected for solid phase peptide synthesis to
investigate whether encrypted antimicrobial peptides can be identified in human proteins
using our prospective methodology. These peptides, named Hs01, 02, 03 and 04, were synthe-
sized by solid phase peptide synthesis, purified by RP-HPLC, and verified by mass spectrome-
try, as described in the material and methods section. Their primary structures and source
proteins are listed in Table 1. A helical wheel plot of Hs01, 02, 03 and 04 is provided to confirm
that these peptides present an amphiphilic nature once structured as α-helical segments fol-
lowing membrane adsorption (Fig 1A). Peptide Hs03 corresponds to amino acids 285–304 of
the N subunit of the human Anaphase-Promoting Complex (PDB:4UI9), and this segment is
almost fully structured as an α-helix in the source protein, as demonstrated in Fig 1B. No
information regarding the three-dimensional structure of the source proteins of the remaining
IAPs could be obtained.
Hs IAPs are α-helical upon membrane adsorption and promote
disturbances in the main phase transition of model vesicles
Far-UV CD scans were obtained for Hs IAPs at 40 μM concentration in phosphate buffer
alone and after the addition of 50-fold molar excess of model phospholipid large unilamellar
vesicles (LUVs) composed of dimyristoylphosphatidylcholine (DMPC) and 2:1 dimyristoyl-
phosphatidylcholine: dimyristoylphosphatidylglycerol (2:1 DMPC:DMPG). Hs IAPs were
mostly unstructured in buffer, although Hs03 and 04, were already nearly 30% helical in this
environment (Table 2). As anticipated, the addition of phospholipid LUVs at 2 mM induced a
Table 1. Peptide code, name, primary structure, source protein and number of amino acid residues of the Hs IAPs synthesized for the present study.
Peptide code Peptide name Primary structure Source protein N. Residues
NP_001093322.2 (185–202) Hs01 LKMLGMLFHNIRNILKTV-NH2 PRAME family member 20 18
NP_001094891.3 (741–756) Hs02 KWAVRIIRKFIKGFIS-NH2 unconventional myosin-Ih 16
NP_037498.1 (285–304) Hs03 FLREFHKWIERVVGWLGKVF-NH2 anaphase-promoting complex subunit 2 20
NP_055421.1 (582–600) Hs04 LFNNYITAALKLLEKLYKV-NH2 probable E3 ubiquitin-protein ligase HERC3 isoform 1 19
https://doi.org/10.1371/journal.pone.0220656.t001
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transition to α-helical structures in the four investigated peptides, as indicated by the far-UV
CD spectra (Fig 2A). The percent helicity of peptides was estimated [23] in buffer and after the
addition of model phospholipid LUVs (Table 2). As previously demonstrated for other IAPs
[6,7], 2:1 DMPC:DMPG LUVs induced higher percent helicity in all peptides, a common fea-
ture among AMPs and IAPs.
To investigate the disturbance promoted by Hs IAPs in the main phase transition of model
membranes, these molecules were added at a 4 mol% ratio to DMPC and 2:1 DMPC:DMPG
LUVs and then submitted to heating thermal scans in a differential scanning calorimeter (Fig
2B). DSC thermograms showed anticipated endothermic transitions characteristic of the phos-
pholipid (P´β!Lα) phase transition [6–8,24]. Thermograms were fit to a non-two state model
with two components, a sharp and a broad peak, as described elsewhere [6,7]. Peptides Hs01
and Hs02 induced mild disturbances in the main phase transition of DMPC LUVs, but dis-
turbed significantly the P´β!Lα transition of 2:1 DMPC:DMPG vesicles. Peptides Hs03 and
04 disturbed more significantly the acyl core of model membranes of both compositions.
These peptides presented pronounced effects in the Transition temperature (Tm), Enthalpy
(ΔH) and van´t Hoff Enthalpy (ΔHvh) of the broad and sharp components of LUVs.
Individual analysis of heating thermal scans of peptide:phospholipid mixtures provides
only a qualitative description of the interaction, and therefore has limited interpretation. By
integrating the Hs IAPs in the framework of membrane active peptides previously introduced
by our group [8], it is possible to evaluate the profile of membrane interaction these peptides
display in relation to other membrane active molecules (Fig 3). The Tm, ΔH and ΔHvh
obtained for the sharp and broad components of the P´β!Lα transition of DMPC and 2:1
DMPC:DMPG LUVs enriched with Hs IAPs were joined to a previous set of 52 membrane
active peptides and submitted to a principal component analysis. Additionally, the first five
Fig 1. a. Helical wheel Edmundson plot of the peptides Hs01, Hs02, Hs03 and Hs04 highlighting their amphiphilic
character. In green are hydrophobic amino acid residues, in blue, polar uncharged residues, in dark blue, negatively
charged residues, and in red are positively charged residues, and b. Structure of the N subunit of the human Anaphase-
Promoting Complex (PDB:4UI9). In detail is the α-helical segment spanning the amino acid residues from 285 to 304,
which correspond to the IAP Hs03.
https://doi.org/10.1371/journal.pone.0220656.g001
Table 2. Percent helicity of the Hs IAPs in buffer, and at a 50-fold molar excess of DMPC and 2:1 DMPC:DMPG
LUVs, estimated by the method of Chen et al.[23].
% Helicity Buffer % Helicity 2:1 DMPC:PG %Helicity DMPC
Hs01 15.1 85.9 40.3
Hs02 4.6 45.5 43.8
Hs03 29.4 88.6 92.9
Hs04 35.6 91.3 50.8
https://doi.org/10.1371/journal.pone.0220656.t002
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principal components were clustered using a hierarchical clustering algorithm, as previously
performed by our group [8]. Such analysis indicates that Hs01 induces a thermal profile in
model membranes similar to the IAPs Gr01 and At01 [7], while Hs02 induced disturbances
that are comparable to the IAP At02 and the natural peptide Magainin-2a [8] (Fig 3). Peptides
Hs03 and Hs04 induced similar thermal profiles in membranes among themselves and can be
compared to the IAP O43312(33–62) [6] and the AMP Nattererin-1 [25] in our reference sys-
tem [8]. Such biophysical analyses using model membranes indicate that the Hs IAPs
Fig 2. Hs IAPs transition to α-helical structure upon interaction with model phospholipid membranes and induce disturbances in the P´β!Lα phase
transition of vesicles. a. Far-UV CD scans were performed to evaluate the secondary structure of Hs IAPs in buffer alone (40 μM solution peptide in
phosphate buffer), represented as a black line, and after the addition of 2 mM DMPC, represented as a red line, or in the presence of 2 mM 2:1 DMPC:DMPG,
blue line. b. Heating thermal scans of DMPC and 2:1 DMPC:DMPG LUVs enriched with 4 mol% IAPs. Black line corresponds to experimental data. Red line
corresponds to a non-two state model fitting with two components of the main phase transition of model vesicles. Hs IAPs and the corresponding LUV
compositions are indicated in each inset of the figure.
https://doi.org/10.1371/journal.pone.0220656.g002
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prospected by the software Kamal are actual membrane disrupting agents, as anticipated, but
present different qualities of membrane interaction.
Hs IAPs are broad antimicrobial agents
The antimicrobial activities of the IAPs Hs01, 02, 03 and 04 were evaluated against a panel of
human pathogenic microorganisms, comprising the yeast C. albicans, the filamentous fungi T.
rubrum, the Gram-positive bacteria S. aureus and S. epidermidis, as well as the Gram-negative
bacteria P. aeruginosa (Table 3). The frog skin peptides Asc-08 [26] and DS01 [27] were used
as controls, along with reference commercial antifungal and antibiotic agents. All Hs IAPs
were antimicrobial towards tested microorganisms with varying potencies (Table 3). IAPs
Hs02 and Hs04 presented minimum inhibitory concentrations (MICs) comparable to
Fig 3. Constellation plot of the dendrogram obtained from HCA categorizes peptides in discrete clusters. The transition
temperature (Tm), enthalpy (ΔH) and van’t Hoff enthalpy (ΔHvh) of the broad and sharp components of DMPC and 2∶1
DMPC:DMPG LUV thermograms following the addition of the Hs IAPs were obtained by adjusting peaks to a non-two state
transition with two components. Data for Hs01, 02, 03 and 04 were appended to 52 other IAPs and AMPs and jointly
submitted to a novel principal component analysis followed by hierarchical clustering (HCA analysis) of the first five
principal components. The corresponding dendrogram is depicted in the form of a constellation plot in dimensionless units.
https://doi.org/10.1371/journal.pone.0220656.g003
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reference AMPs (Table 3). Indeed, Hs02 was the most potent peptide against all evaluated
microorganisms, including control AMPs. Moreover, Hs02 was the only molecule with signifi-
cant inhibitory activity towards P. aeruginosa, indicating a wide spectrum of activity.
Investigations on the cytotoxicity of Hs IAPs, with emphasis in the IAP
Hs02
The hemolytic effect of Hs IAPs on human erythrocytes was evaluated. Judging by the peptide
concentration that induces 50% hemolysis (Table 3, SC50), Hs IAPs are in general as hemolytic
as the reference AMP DS01 [27], in consonance with results obtained for other IAPs from
plant proteins [7]. The MTT reduction assay was conducted in primary macrophages to assess
putative cytotoxic effects of Hs IAPs to this cell type (S1 Fig). Hs03 and 04 reduced the viability
of peritoneal macrophages to 50% at approximately 10 μM, while Hs01 and 02 produced the
same effect even at the lowest concentration evaluated (125 nM). To further investigate the
putative cytotoxicity detected for Hs02, this peptide was incubated with mouse BALB/cN mac-
rophages (J774A.1) cells at 0.1, 1 and 10 μM concentrations and analyzed by flow cytometry.
Fig 4A shows that Hs02 did not cause significant (p<0.05) reduction in the viability of mouse
BALB/cN macrophages (J774A.1) up to 10 μM concentration when compared with a DMEM
untreated control, while the hydrogen peroxide (H2O2) cell death control decreased signifi-
cantly (p<0.05) the cell viability. Additionally, analyses using annexin-V FITC (apoptosis
marker) and propidium iodide (PI, necrosis marker) staining were performed to distinguish
apoptotic cells from necrotic cells by flow cytometry in control and experimental groups
[28,29] (Fig 4B). Cells treated with the peptide did not present significant apoptosis or necrosis
in relation to the DMEM control group, confirming the cell viability assay.
Hs02 modulates LPS-induced release of inflammatory mediators
Hs02 was evaluated in its capacity to elicit the release of inflammatory mediators in macro-
phages. No significant release of TNF-α, IL-1β, IL-17, or IL-6 was detected in THP-1 cells after
stimulation with Hs02 at 1 μM concentration (S2 Fig). Additionally, Hs02 did not elicit the
release of eicosanoids LTB4 or PGE2 in the same cell type at the same concentration. To inves-
tigate putative suppressive effects in the pro-inflammatory response induced by lipopolysac-
charides in macrophages, cells were stimulated with 500 ng/mL LPS for 4h, and incubated
with Hs02 at 0.1, 1 and 10 μM for 24h, followed by the quantification of TNF-α. As expected,
Table 3. Minimum inhibitory concentration towards microorganisms and hemolytic activity of Hs IAPs.
Minimum inhibitory concentration (μM ± SD) Hemolytic activity
SC50
�
C. albicans T. rubrum S. aureus S. epidermidis P. aeruginosa
Hs01 64.0 ± 0.0 NA 128.0 ± 0.0 64.0 ± 0.0 NA > 128 μM
Hs02 1.67 ± 0.57 8.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 1.67 ± 0.57 > 128 μM
Hs03 32.0 ± 0.0 256.0 ± 0.0 32.0 ± 0.0 21.33 ± 9.24 NA > 128 μM
Hs04 8.0 ± 0.0 32.0 ± 0.0 4.0 ± 0.0 5.33 ± 2.31 NA 64 μM
Asc-8 10.67 ± 4.61 - 1.67 ± 0.57 4.0 ± 0.0 4.0 ± 0.0 32 μM
DS01 5.33 ± 2.31 128.0 ± 0.0 8.0 ± 0.0 4.0 ± 0.0 2.0 ± 0.0 > 128 μM
Fluconazol 1.63 ± 0.0 - - - -
Amphotericin b 0.27 ± 0.0 - - - -
Ampicilin - - 5.38 ± 0.0 43.10 ± 0.0 NA -
Gentamicin - - 0.26 ± 0.0 0.26 ± 0.0 0.13 ± 0.0 -
� IAP concentration that at least 50% of red blood cells remain intact.
https://doi.org/10.1371/journal.pone.0220656.t003
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LPS treatment of mouse macrophages resulted in a significant release of TNF-α (Fig 5A). Hs02
inhibited the release of TNF-α in LPS-primed cells even at the lowest peptide concentration
evaluated, 0.1 μM (Fig 5A). Additionally, the ability of Hs02 to modulate cellular activation by
investigation the lipid droplets biogenesis was analyzed. Within immune cells, LDs are consid-
ered as structural markers of inflammation [30] being able to store arachidonic acid, an essen-
tial component for the production of inflammatory mediators such as eicosanoids. Lipid
droplet biogenesis of LPS-primed macrophages was quantified using the BODIPY dye assay
coupled to flow cytometry. As expected, priming macrophages with LPS (Fig 5B, LPS) induced
an increase of lipid droplet biogenesis compared to unstimulated macrophages (Fig 5B, UNS).
Addition of Hs02 after 4h of the priming of macrophages with LPS at 0.1 μM concentration
reduced LPS-induced lipid droplet biogenesis, reinforcing the anti-inflammatory activity of
this peptide at this concentration (Fig 5B). DS01, our reference AMP, was unable to reduce
LPS-induced release of TNF-α up to 10μM concentration, the highest concentration tested (S3
Fig).
Hs02 structures as an α-helix in the presence of DPC-d38 micelles
The 3D structure of Hs02 was investigated by solution 1H NMR spectroscopy in DPC-d38
micelles. Except for residue K1, amino acid spin systems for the other 15 residues were
Fig 4. a. Cytotoxicity evaluation in the mouse BALB/cN macrophage (J774A.1) cell line after exposure for 24 h at 0.1,
1.0 and 10 μM concentrations. DMEM was used as a negative control. Cells were analyzed by flow cytometry (20,000
events/sample). b. Evaluation of the cell death mechanism mediated by Hs02 in J774A.1 cells after exposure for 24 h at
0.1, 1.0 and 10 μM concentrations using annexin-V FITC (apoptosis marker) and propidium iodide (PI, necrosis
marker) staining. Cells were analyzed by flow cytometry (20,000 events/sample). The values are expressed as
mean ± SEM. � p<0.05 and ���� p<0.0001 versus DMEM untreated control group. # p<0.05 versus apoptosis staining
for each respective group.
https://doi.org/10.1371/journal.pone.0220656.g004
Fig 5. TNF-α secretion and lipid droplet biogenesis evaluation. a. Murine peritoneal macrophages from C57BL/6
mice were pre-treated or not with LPS (500 ng/ml) for 4h and then stimulated or not with Hs IAPs (0.1, 1.0 and
10 μM), incubated for 24h and TNF-α levels measured by ELISA b. In parallel, murine peritoneal macrophages from
C57BL/6 mice were pre-treated or not with LPS (500 ng/ml) for 4h and then stimulated or not with Hs IAPs (0.1 μM),
incubated for 24h and lipid droplets were quantitated by flow cytometry (B). The values are expressed as mean ±SEM.
� p<0.05 and ���� p<0.0001 versus DMEM control group.
https://doi.org/10.1371/journal.pone.0220656.g005
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identified and unequivocally assigned from the TOCSY and NOESY spectra (S4 Fig). The
chemical shifts are reported in S1 Table and are deposited in the BMRB data bank with acces-
sion number 30509. The secondary structure of Hs02 was evaluated by calculating the chemi-
cal shift index (CSI) [31] of Hα backbone atoms, and it confirmed a propensity for helical
structure spanning residues Ala3-Phe14 (S5 Fig). These results were also consistent with the
connectivity obtained from the NOESY spectra. NOE panel (S5 Fig) and NOE restrains
(Table 4) indicate medium-range NOEs, specially dαN(i, i+3), dαN(i, i+4) NOE, which are
typical for helically folded peptides. An ensemble of micelle-bound structures was calculated
using 291 inter-proton distance restraints and 24 dihedral angles. Statistical analyses of the
constraints are described in Table 4.
Hs02 peptide has a well-defined structure in the presence of DPC-d38 micelles and adopts
α-helix conformation ranging from residues Ala3-Phe14 (Fig 6A). It is interesting to note that
its N-terminal region is disordered. As shown in Table 4, RMSD values drop significantly if
the superposition is carried out over residues Ala3-Phe14, and indicate that the N-terminal has
a random structure. An analysis of Ramachandran plot demonstrates that more than 96.4% of
all residues are in the most favored regions of the diagram and 2.9% are in allowed regions,
indicating a high stereochemical quality of NMR models. Only 0.7% of the residues are located
in disallowed regions; however, these are located near the amino-terminus, which is structur-
ally undefined. The pronounced amphiphilic nature of Hs02 is demonstrated in Fig 6B.
Discussion
The present work describes the uncovering of Intragenic Antimicrobial Peptides (IAPs)
encrypted in proteins encoded in the human genome, further exploring the antimicrobial
activity, cytotoxicity, and putative immunomodulatory effects of representative molecules.
While the release of antimicrobial fragments due to the partial hydrolysis of proteins from the
human proteome has been described before [4,32,33], to our best knowledge, this is the first
report of a large-scale in silico methodological-based enterprise to the uncovering of encrypted
Table 4. Structural statistics of the best 10 NMR structures of Hs02.
NOE Restrains
Total number of distance Restraints 291
Number of intraresidue restraints 207
Number of sequential restraints (i, i+1) 40
Number of medium range restraints (i, i+j)j = 2,3,4 44
Dihedral angle 24
RMSD (Å)a –All residues
Backbone 0.51
Backbone and heavy atoms 1.27
RMSD (Å)a,b –Helical segment
Backbone 0.18
Backbone and heavy atoms 0.72
Ramachandran plot analysisa
Residues in most favored regions 96.4%
Residues in allowed regions 2.9%
Residues in disallowed regions 0.7%
aData from CCPNMR using 10 lowest energy structures
bfrom 3–14.
https://doi.org/10.1371/journal.pone.0220656.t004
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Fig 6. a. Ribbon representation of the lowest energy structure of Hs02 (left) and backbone alignment of the final 10
lowest-energy structures of Hs02 (right) in the presence of DPC-d38 micelles. b. Surface hydrophobic feature of Hs02
peptide. Side chain amino acid properties are showed in the following color code: red for the positively charged
residues, cyan for the polar residues and green for the hydrophobic residues. The structure on the right side shows the
molecule rotated 180˚ around the vertical axis (PDB: 6MBM).
https://doi.org/10.1371/journal.pone.0220656.g006
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AMPs from human proteins. This work reinforces our previous claims that encrypted antimi-
crobial peptides are encountered in proteins from the most varied sources [6–8], and therefore
not restricted to certain organisms or classes of molecules with involvement in the immune
response.
The software Kamal was used to evaluate internal fragments of proteins encoded in the
human genome that share similitude with α-helical amphiphilic AMPs [6–8]. The physico-
chemical properties under evaluation by Kamal and their reference ranges were determined in
previous works [6,7] and are in constant evolution. In its current version, the software was
programmed to identify amphiphilic segments of proteins using a set of amino acid rules, as
an alternative to the calculation of the hydrophobic moment (μH) [34] of internal sequences.
Four Hs IAPs were chosen for chemical synthesis and biophysical investigations, mainly the
determination of peptide structures in buffer and after the addition of a molar excess of model
phospholipid LUVs, as well as the influence of peptides on the main phase transition of phos-
pholipid vesicles. As expected from previous reports [6,7], the Hs IAPs varied in their second-
ary structure content in buffer, and in their extent of structuration as α-helical segments upon
titration with DMPC and 2:1 DMPC:DMPG LUVs. By incorporating the Hs IAPs in the
framework of membrane active peptides previously introduced by our group [8] it was possi-
ble to evaluate putative similarities in membrane-binding behavior of these molecules with
previously acquired IAPs and AMPs using the same methodology. According to our model,
the IAP Hs02 altered the main phase transition of model membranes (P´β!Lα) similarly to
Magainin-2a, as depicted in Fig 3. Both Magainin-2a and Hs02 do not affect significantly the
main phase transition of DMPC vesicles, while they produce similar effects in the main phase
transition of 2:1 DMPC:DMPG LUVs. The effect of 4 mol% Hs02 in membranes of the latter
composition is consistent with a more superficial location [24], and further investigations
should be carried out to evaluate the meaning and the extent to which Hs02 and Mag-2a are
similar in mechanistic terms.
The antimicrobial activity of Hs IAPs towards common human pathogenic microorgan-
isms was also evaluated. The MICs determined for these microorganisms were comparable to
other IAPs obtained from plant proteins, likewise their hemolytic activities [7]. Unsurpris-
ingly, the Hs IAPs presented wide antimicrobial spectra, being active against Gram-positive
and -negative bacteria as well as yeasts, reinforcing our previous claims that these peptides are
capable to hinder the growth of microorganisms despite their varied membrane structures [8].
Due to its pronounced activity and amplitude of antimicrobial spectrum, the IAP Hs02 was
chosen for further evaluation. Although hemolysis was not pronounced for Hs02, which points
to a high selectivity index, MTT of primary murine macrophages exposed to this molecule
indicated significant toxicity. Potent amphiphilic α-helical AMPs are often cytotoxic [35],
which prompted us to evaluate this subject further by flow cytometry using the J774A.1 macro-
phage cell line. Hs02 was tolerated up to 10μM concentration by this cell line, suggesting that
putative fundamental compositional differences between primary murine macrophages and
the J774A.1 macrophage cell line might make the former cell lineage more susceptible. MTT
assays were also conducted in HaCat cells (S6 Fig), and statistically significant cytotoxicity for
this peptide was observed only at 10μM concentration. No significant apoptosis or necrosis
was induced by Hs02 up to 10μM concentration in J774A.1 in relation to DMEM control as
shown by annexin and PI analyses. The traditional apoptosis pathway is a form of pro-
grammed and organised cell death that prevents triggering of local inflammatory process,
while necrosis is a form of non-regulated cell death that causes cell lysis and exposition of its
content [36]. In any case, Hs02 should be considered as a proof-of-concept, since human pro-
teins might hold other encrypted IAPs with still possibly higher selectivity and potency
towards microorganisms.
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The anti-inflammatory effect of Hs02 in murine macrophages primed with LPS was also
investigated. Lipopolysaccharide-neutralizing activity has been observed in several AMPs, and
is now considered a common feature to this class of molecules [37]. The LPS-neutralizing abil-
ity of AMPs is often attributed to direct binding and dissolution of LPS aggregates, which
reduces the TLR4 agonist capacity [37]. It is noteworthy that Hs02 displayed significant TNF-
α suppressing activity in murine macrophages already primed for 4h with LPS, inhibiting the
release of this cytokine at peptide concentrations as low as 0.1 μM. As demonstrated for other
synthetic cationic peptides [38], Hs02 has thus not only prophylactic, but putative therapeutic
potential as a potent anti-inflammatory molecule in sepsis models.
Once CD results showed that the Hs02 peptide adopts a helical conformation upon titration
with model membranes, its structure was further investigated by solution NMR spectroscopy
in the presence of DPC-d38 micelles. 1H NMR data showed that, in the presence of DPC
micelles, Hs02 achieved a well-defined secondary structure characterized by the presence of an
α-helical fold that spans throughout residues Ala3-Phe14, besides a prominent amphiphilic pat-
tern, with a polar face enriched by positively charged residues (Arg5, Arg8, Lys9, Lys12). How-
ever, the percent helicity estimated by CD for Hs02 in DMPC LUVs is lower from that
obtained for DPC-d38 micelles in the NMR solution structure. This might be due to the higher
spacing of phospholipids headgroups in micelles in relation to lipid bilayers, and to the differ-
ent peptide/lipid molar ratios used in CD and NMR experiments. According to the NMR data,
the N-terminal region of Hs02 peptide exhibited a more flexible structure. Indeed, the Trp2
residue has a flexible side chain and, therefore, the position of its aromatic ring was not well
defined, ranging from both the hydrophobic to the hydrophilic region of the molecule. The
Trp sidechain is known to have an affinity for interfacial regions of lipid bilayers [39], which
may increase its mobility.
The present work is based on the premise that proteins encoded by the human genome
present amphiphilic α-helical structural segments, which, decrypted from their parent proteins
and chemically synthesized as individual entities, can be used as antimicrobial and anti-
inflammatory agents. Given that the membrane-permeabilizing and LPS-neutralizing activities
commonly encountered in AMPs [37] are most likely due to their amphiphilic nature, we
demonstrate that IAPs are actual alternatives to HDPs as pharmaceutical agents or in their
many applications. Although the results presented herein should be viewed as a proof-of-con-
cept, our findings suggest that the human genome holds an unexplored potential as a source of
bioactive compounds with biotechnological potential in human health. Novel IAPs with more
pronounced selectivity to microorganisms and anti-inflammatory potential are yet to be
uncovered as novel tools for their recognition and testing are perfected or made available.
Materials and methods
Peptide filtering, selection and solid phase synthesis
Proteins were downloaded in .FASTA format from The UniProt database (www.uniprot.org)
in October 2017, by searching for the keyword Homo sapiens under the term Organism (OS).
The filtering of putative IAPs was performed using the software Kamal v 2.0 (http://www.
cenargen.embrapa.br/kamal/) operating in mode 1. Proteins were scanned for putative
encrypted IAPs ranging from 16 to 22 amino acid residues with the characteristic periodicity
of α-helical amphiphilic segments, considering three possible polar angles, θ = 192˚, 160˚ and
128˚. Amino acid rules were created for the hydrophobic and hydrophilic faces based in a
hydrophobicity scale [40]: amino acids Ala, Phe, Ile, Leu, Met, Val, and Trp were allowed in
the hydrophobic face, while the hydrophilic face was less restrictive, allowing Ala, Asp, Glu,
Gly, His, Lys, Met, Asn, Gln, Arg, Ser, Thr, and Tyr. Any putative segment containing either
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Pro or Cys was discarded. Additionally, only peptides with average hydrophobicity from -0.5
to 0.7 (TM scale [40]), net charge from +2 to +6, and aggregation tendency from -20 to +50
(Na4vSS parameter, Aggrescan algorithm [41]) were selected. These physicochemical parame-
ters were chosen based on previous works by our group [6–8]. Four molecules were selected
and chemically synthesized using Fmoc/t-butyl strategy [42]. The AMPs DS01 [27] and Asc-8
[26], were also synthesized and used as references. Peptide chain elongation was performed on
Rink Amide resin, yielding C-terminal amidated peptides.
Mass spectrometry analyses, HPLC purification and quantification
Synthetic peptides were analyzed by mass spectrometry to confirm peptide mass and amino
acid sequence. Hs01-04 were individually mixed and co-crystallized with α-cyano-4-hydroxy-
cinnamic acid matrix (Fluka) at 10 mg.mL-1 in a MALDI target plate. Experiments were car-
ried out in an UltrafleXtreme MALDI-TOF/TOF (Bruker Daltonics). Peptides monoisotopic
mass were obtained in reflector mode over a range of 700–3500 m/z with external calibration
using Peptide Calibration Standard II (Bruker Daltonics). Peptide primary structures were
inferred by means of manual interpretation of fragmentation spectra.
Reverse phase HPLC (RP-HPLC) of the synthetic peptides was performed in a LC-20A
Prominence (Shimadzu Co.) using a Jupiter C18 10 μm column (Phenomenex) at a flow rate of
10 mL.min-1. Ultrapure Milli-Q water and acetonitrile (J.T. Baker) added with 0.1% (v/v) tri-
fluoroacetic acid (TFA) were used as solvent A and B, respectively. Fractions were manually
collected and analyzed by mass spectrometry to confirm the elution time of each synthetic
peptide.
Peptides containing Trp or Tyr residues were quantified using calculated molar absorption
coefficients [43]. The remaining peptides were quantified using the UV absorbance of the pep-
tide bond according to the literature [44].
Differential scanning calorimetry (DSC) and circular dichroism (CD)
assays
DMPC and 2:1 DMPC:DMPG (w/w) large unilamellar vesicles were prepared as described in
the literature [6,7] and quantified using the ammonium ferrothiocyanate method [45]. Phos-
pholipids were weighted, dissolved in chloroform, dried in a rotary evaporator, resuspended in
20 mM sodium phosphate–NaOH, 150 mM NaCl, pH 7.4, hand-shaken until the formation of
a cloudy solution and passed through a 100 nm polycarbonate membrane using a mini-
extruder. DSC analyses were also performed as previously described [7]. Briefly, thermograms
were obtained using a VP-DSC (GE Healthcare) at a temperature range from 10 to 40 ˚C at a
scanning rate of 0.5 ˚C/min. Peptides were added to fresh samples of 0.5 mM LUVs at a con-
centration of 20 μM (0.04 mol/mol peptide/phospholipids) at room temperature, immediately
followed by DSC data acquisition. Each sample was subjected to various thermal scans until
there were no distinguishable changes in the thermal profile of the main phase transition
(P0β!Lα) of phospholipids between individual scans. Data was concentration normalized,
baseline subtracted (linear connect), and fit to a non two-state transition with two user deter-
mined peaks via the MicroCal Origin software v7.0. Re-scans for selected cases were acquired
using fresh peptide and LUVs solutions to check the reproducibility of the data.
CD experiments were conducted on a Jasco-J815 spectropolarimeter (Jasco International
Co.) as previously described [7]. Spectra were registered at room temperature from 200 to 260
nm as an average of 4 readings using a 0.1 cm path length cell, data pitch of 0.2 nm and a
response time of 0.5 s. Data scans of buffer and 2 mM DMPC and 2:1 DMPC:DMPG LUVs
solutions were acquired and subtracted from each peptide data. Peptides were scanned at a
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concentration of 40 μM in buffer and then 50 fold excess of DMPC and 2:1 DMPC:DMPG
LUVs were added, resulting in a molar ratio of 0.02 peptide/phospholipid. The spectra were
converted to mean residue ellipticity and readings at 222 nm ([θ]222) were used to estimate
helix percentages [23].
Evaluation of antimicrobial activity of IAPs
Protocols M7-A10 [46], M27-A3 [47] and M38-A2 [48] from Clinical & Laboratory Standards
Institute (CLSI) were used to test the susceptibility of bacteria, yeasts and filamentous fungi to
the Hs IAPs. Briefly, Hs IAPs ranging from 0.5 to 256 μM were tested against microorganisms
in a final volume of 100μL. Tests were performed in polystyrene flat-bottom 96 wells micro-
plates and each test consisted of three biological repetitions with 2 technical replicates each.
The minimum inhibitory concentration (MIC) was defined as the concentration that no cells/
hyphae were detected when visualized by optical microscopy. ATCC reference strains: Can-
dida albicans 90028, Staphylococcus aureus 25923, Pseudomonas aeruginosa 27853, Trichophy-
ton rubrum 28189, Staphylococcus epidermidis 12228.
Cytotoxicity assay
The cytotoxicity of Hs IAPs was performed using human red blood cells in strict accordance
with relevant guidelines and regulations (Ethical committee–UnB # 1.939.989 as described
elsewhere [7]. Cytotoxic effect of IAPs was evaluated by MTT assay and flow cytometry analy-
sis using murine peritoneal macrophages from C57BL/6 mice or a BALB/cN-derived macro-
phages (J774A.1) cell line. For cell viability assays using MTT, murine peritoneal macrophages
from C57BL/6 mice were plated in triplicate wells in 96-well plates at a density of 1.0 × 105
cells per well and stimulated or not with different concentrations of Hs IAPs (0.1, 1 and
10 μM) and incubated for 24h. After that, 20μl of a solution of 3-(4,5-Dimethyl-thiazol-2-yl)-
2,5-diphenyl-tetrazolium bromide (MTT, Sigma) was added to each well (5 mg/ml of MTT in
phosphate buffered saline). The plates were incubated at 37˚C for 3 hours and then processed
as previously described [49]. Cell death was analysed by annexin V-FITC/PI staining followed
by flow cytometry analysis. Mouse BALB/cN macrophage (J774A.1) cell line was acquired
from ATCC (number TIB-67) and cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)
(Life) supplemented with 10% heat inactivated foetal bovine serum (Life) and 1% antibiotic
solution (100 IU/mL penicillin/100 μg/mL streptomycin, Life) at 37˚C, 5% CO2, in a humidi-
fied atmosphere. J774A.1 cells were seeded into 96-well culture plates in DMEM culture
medium for 2 h at 37˚C and 5% CO2 in a humid atmosphere at a density of 1.0 × 105 cells, and
stimulated or not with different concentrations of Hs IAPs (0.1, 1 and 10 μM). The plates were
incubated for 24 h, washed in PBS, and resuspended in 100 μL of binding buffer (10 mM
HEPES/NaOH pH 7.4, 140 mM NaCl, ad 2.5 mM CaCl2). Cells were then treated with 2 μL of
annexin-V FITC in Aqueous buffered solution containing BSA and�0.09% sodium azide (BD
Pharmingen) and 2 μL of propidium iodide (PI, 50 μg/mL) for 15 min in the dark at room
temperature. Next, 100 μL binding buffer was added and a total of 20,000 events were collected
per sample in flow cytometer (BD LSRFortessa).
TNF-α measurement by ELISA
The modulation of pro-inflammatory cytokine TNF-α secretion induced by IAPs was evalu-
ated by ELISA. Murine peritoneal macrophages from C57BL/6 mice were pre-treated or not
with LPS (500 ng/ml) for 4h and then stimulated or not with different concentrations of Hs
IAPs (0.1, 1 and 10 μM) and incubated for 24 h. As a positive control, cells were stimulated
only with LPS (500 ng/ml) for 24h. Supernatant TNF-α concentration was detected by ELISA
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with a R&D Systems (USA) kit. Microtiter plates were coated overnight at room temperature
with capture antibody and blocked with Reagent Diluent for 1 hour. Serially diluted samples
were added to the wells in triplicate and incubated overnight at 4˚C. After extensive washing,
the cells were incubated with detection antibody and then Streptavidin-HRP. After washing,
substrate solution was added and the plates were incubated for 15 minutes at room tempera-
ture. Plates were read after adding the stop solution at 450nm using SpectraMax M3spectro-
photometer (Molecular Devices).
Lipid droplets biogenesis
The ability of IAPs to activate cells was evaluated by analyzing lipid droplet biogenesis, an
inflammatory cell activation marker. The lipid droplets were quantitated by flow cytometry.
Murine peritoneal macrophages from C57BL/6 mice were pre-treated or not with LPS (500
ng/ml) for 4h and then stimulated or not with Hs IAPs (0.1 μM) and incubated for 24 h. After,
cells were dissociated with trypsin (GIBCO), washed with PBS, incubated with the Bodipy
(Sigma Aldrich, 50 nM) diluted in PBS for 30 minutes at 4˚C in the dark. Cells were washed
twice with PBS, resuspended in 500μL of PBS and stored at 4˚C until reading by FACS Calibur
using the FITC channel. FlowJo software was used to plot data and determine the median fluo-
rescence intensity (MFI).
1H NMR spectroscopy and structures calculations
The lyophilized Hs02 peptide was dissolved in 600 μL PBS buffer at pH 7.0 and H2O/D2O
(90:10, v/v) to a final concentration of 2 mM in 50 mM of DPC-d38. Additionally, 0.5%
sodium-2,2,3,3-d4-3-trimethylsilylpropionate (TMSP-d4) was added as chemical shift refer-
ence internal standard. All 1H NMR experiments were performed on a Bruker Avance III HD
600 spectrometer operating at 14 T for 1H, at 25 ºC. The assignment of the peptide resonance
peaks were carried out by two-dimensional (2D) experiments: total correlated spectroscopy
(TOCSY) and nuclear Overhauser effect spectroscopy (NOESY). 2D spectra were acquired
with 4096 complex points and 512 τ1 increments. The H2O signal was attenuated with excita-
tion sculpting using 180 water-selective pulse. TOCSY spectra were obtained with a mixing
time of 80 ms and NOESY spectra were recorded with a mixing time of 200 ms. The spectra
were processed using NMRFX Processor software [50] and the contour maps were visualized
using CCPNMR (version 2.4) software [51]. 1H chemical shifts were assigned according to
standard procedures [52]. The NOEs were characterized based on the height of the cross
peaks. The upper bounds for the NOE constraints were calibrated based in the r-6 distance
dependence of the NOE, in three classes: strong (� 1.72 Å), medium (� 3.2 Å) and weak
(� 8.0 Å) [53]. Structures were calculated using ARIA (version 2.3.1)[54] and CNS (version
1.2)[55] software. Several cycles of ARIA were performed using standard protocols and, after
each cycle, rejected restraints, violations and assignments were analyzed. The ensemble of 10
lowest energy structures was chosen to represent the peptide solution 3D structure. NMR
structures were deposited at PDB (www.rcsb.org) and were assigned with PDB code 6MBM.
Statistical analysis
Results are reported as mean ± SD or mean ± SEM unless otherwise noted. Comparisons
between groups were performed using analysis of variance (ANOVA) followed by Bonferroni’s
multiple comparison test using GraphPad Prism version 6.0 (GraphPad Softwares, USA), at
confidence interval of 95% (p< 0.05 was considered significant).
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Supporting information
S1 Table. Chemical shifts 1H-NMR (ppm) to the HS02 peptide in micelle solution DPC-
d38 50 mM, at 25˚C and pH 7.0.
(PDF)
S1 Fig. MTT assays for the Hs IAPs using murine peritoneal macrophages from C57BL/6
mice. Murine peritoneal macrophages from C57BL/6 mice were plated in triplicate wells in
96-well plates and stimulated or not with different concentrations of Hs IAPs and incubated
for 24h. 3-(4,5-Dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT, Sigma) was
added to each well at 10% (5 mg/ml MTT in phosphate buffered saline). The plates were incu-
bated at 37˚C for 3 hours with a) Hs01, b) Hs02, c) Hs03 and d) Hs04, and then processed as
previously described [49].
(TIF)
S2 Fig. THP-1 human monocytes were stimulated with Hs02 (1 μM), incubated for 24h and
cytokines a) IL-1β, b) IL-6, c) IL-17, d) TNF-α levels were measured by ELISA. Additionally,
eicosanoids e) LTB4 f) PGE2 levels were measured by EIA. The values are expressed as
mean ± SEM.
(TIF)
S3 Fig. TNF-α release in murine macrophages. Murine peritoneal macrophages from
C57BL/6 mice were pre-treated or not with LPS (500 ng/ml) for 4h and then stimulated or not
with the AMP DS01 (10, and 1 μM), incubated for 24h and TNF-α levels measured by ELISA.
The values are expressed as mean ±SEM. � p<0.05 and ���� p<0.0001 versus DMEM control
group.
(TIF)
S4 Fig. HN region of A) 1H TOCSY and B) 1H NOESY spectra obtained for 2 mM of Hs02 in
the presence of 50 mM of DPC-d38 at 25˚C and pH 7.0.
(TIF)
S5 Fig. a. Pattern of NOE connectivities involving sequential and medium proton distances of
Hs02. The thickness of the bar indicates the intensities of NOEs. b. Hα CSI for Hs02.
(TIF)
S6 Fig. MTT assays for the Hs IAPs using HaCat cells. HaCat cells were plated in triplicate
wells in 96-well plates and stimulated or not with different concentrations of Hs IAPs (0.1, 1
and 10 μM) and incubated for 24h. 3-(4,5-Dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium
bromide (MTT, Sigma) was added to each well at 10% (5 mg/ml MTT in phosphate buffered
saline). The plates were incubated at 37˚C for 3 hours with the assayed peptides and then pro-
cessed as previously described [49].
(TIF)
Acknowledgments
We are grateful for the invaluable technical contribution of the staff of all laboratories involved
in the present work.
Author Contributions
Conceptualization: Guilherme D. Brand, Jose´ Roberto S. A. Leite, Kelly G. Magalhães, Aline
L. Oliveira, Carlos Bloch, Jr.
Intragenic antimicrobial peptides encrypted in human proteins
PLOS ONE | https://doi.org/10.1371/journal.pone.0220656 August 6, 2019 16 / 20
Data curation: Guilherme D. Brand, Marcelo H. S. Ramada.
Formal analysis: Guilherme D. Brand.
Investigation: Marcelo H. S. Ramada, Ju´lia R. Manickchand, Rafael Correa, Dalila J. S.
Ribeiro, Michele A. Santos, Andreanne G. Vasconcelos, Fernando Y. Abrão, Maura V.
Prates, Carlos Bloch, Jr.
Methodology: Rafael Correa, Dalila J. S. Ribeiro, Michele A. Santos, Andreanne G. Vasconce-
los, Andre´ M. Murad, Jose´ L. Cardozo Fh.
Software: Andre´ M. Murad, Jose´ L. Cardozo Fh.
Writing – original draft: Guilherme D. Brand, Jose´ Roberto S. A. Leite, Kelly G. Magalhães,
Aline L. Oliveira, Carlos Bloch, Jr.
Writing – review & editing: Guilherme D. Brand.
References
1. Brand GD. Estrate´gias para prospecc¸ão e predic¸ão de peptı´deos bioativos [Internet]. Universidade de
Brası´lia. 2007. Available: http://repositorio.unb.br/handle/10482/1373
2. Ivanov VT, Karelin AA, Philippova MM, Nazimov I V., Pletnev VZ. Hemoglobin as a source of endoge-
nous bioactive peptides: The concept of tissue-specific peptide pool. Biopolymers. John Wiley & Sons,
Ltd; 1997; 43: 171–188. https://doi.org/10.1002/(SICI)1097-0282(1997)43:2<171::AID-BIP10>3.0.
CO;2-O PMID: 9216253
3. Phelan M, Aherne A, FitzGerald RJ, O’Brien NM. Casein-derived bioactive peptides: Biological effects,
industrial uses, safety aspects and regulatory status. Int Dairy J. Elsevier; 2009; 19: 643–654. https://
doi.org/10.1016/J.IDAIRYJ.2009.06.001
4. Bjo¨rstad A, Fu H, Karlsson A, Dahlgren C, Bylund J. Interleukin-8-derived peptide has antibacterial
activity. Antimicrob Agents Chemother. American Society for Microbiology; 2005; 49: 3889–95. https://
doi.org/10.1128/AAC.49.9.3889-3895.2005 PMID: 16127067
5. Dale CS, Pagano RDL, Rioli V. Hemopressin: a novel bioactive peptide derived from the alpha1-chain
of hemoglobin. Mem Inst Oswaldo Cruz. 2005; 100 Suppl: 105–6. PMID: 15962106
6. Brand GD, Magalhães MTQ, Tinoco MLP, Aragão FJL, Nicoli J, Kelly SM, et al. Probing protein
sequences as sources for encrypted antimicrobial peptides. PLoS One. 2012; 7: e45848. https://doi.
org/10.1371/journal.pone.0045848 PMID: 23029273
7. Ramada MHS, Brand GD, Abrão FY, Oliveira M, Filho JLC, Galbieri R, et al. Encrypted Antimicrobial
Peptides from Plant Proteins. Sci Rep. 2017; 7: 13263. https://doi.org/10.1038/s41598-017-13685-6
PMID: 29038449
8. Brand GD, Ramada MHS, Genaro-Mattos TC, Bloch C. Towards an experimental classification system
for membrane active peptides. Sci Rep. 2018; 8. https://doi.org/10.1038/s41598-018-19566-w PMID:
29352252
9. Tsai CJ, Nussinov R. Hydrophobic folding units at protein-protein interfaces: implications to protein fold-
ing and to protein-protein association. Protein Sci. 1997; 6: 1426–37. https://doi.org/10.1002/pro.
5560060707 PMID: 9232644
10. Tsai C-J, Nussinov R. Hydrophobic folding units derived from dissimilar monomer structures and their
interactions. Protein Sci. 2008; 6: 24–42. https://doi.org/10.1002/pro.5560060104 PMID: 9007974
11. Tsai C-J, Xu D, Nussinov R. Protein folding via binding and vice versa. Fold Des. 1998; 3: R71–R80.
https://doi.org/10.1016/S1359-0278(98)00032-7 PMID: 9710571
12. Tsai CJ, Maizel J V, Nussinov R. Anatomy of protein structures: visualizing how a one-dimensional pro-
tein chain folds into a three-dimensional shape. Proc Natl Acad Sci U S A. 2000; 97: 12038–43. https://
doi.org/10.1073/pnas.97.22.12038 PMID: 11050234
13. Flores SC, Lu LJ, Yang J, Carriero N, Gerstein MB. Hinge Atlas: relating protein sequence to sites of
structural flexibility. BMC Bioinformatics. 2007; 8: 167. https://doi.org/10.1186/1471-2105-8-167 PMID:
17519025
14. Taylor D, Cawley G, Hayward S. Classification of domain movements in proteins using dynamic contact
graphs. Roccatano D, editor. PLoS One. 2013; 8: e81224. https://doi.org/10.1371/journal.pone.
0081224 PMID: 24260562
Intragenic antimicrobial peptides encrypted in human proteins
PLOS ONE | https://doi.org/10.1371/journal.pone.0220656 August 6, 2019 17 / 20
15. Wang G. Human Antimicrobial Peptides and Proteins. Pharmaceuticals. 2014; 7: 545–594. https://doi.
org/10.3390/ph7050545 PMID: 24828484
16. Hancock REW, Haney EF, Gill EE. The immunology of host defence peptides: beyond antimicrobial
activity. Nat Rev Immunol. Nature Publishing Group; 2016; 16: 321–334. https://doi.org/10.1038/nri.
2016.29 PMID: 27087664
17. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. Beta-defensins: linking innate
and adaptive immunity through dendritic and T cell CCR6. Science. 1999; 286: 525–8. Available: http://
www.ncbi.nlm.nih.gov/pubmed/10521347 https://doi.org/10.1126/science.286.5439.525 PMID:
10521347
18. Kahlenberg JM, Kaplan MJ. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune
disease. J Immunol. 2013; 191: 4895–901. https://doi.org/10.4049/jimmunol.1302005 PMID: 24185823
19. Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C, et al. The antimicrobial peptide LL37 is a
T-cell autoantigen in psoriasis. Nat Commun. Nature Publishing Group, a division of Macmillan Publish-
ers Limited. All Rights Reserved.; 2014; 5: 5621. Available: https://doi.org/10.1038/ncomms6621
PMID: 25470744
20. Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune
defense. Trends Immunol. NIH Public Access; 2009; 30: 131–41. https://doi.org/10.1016/j.it.2008.12.
003 PMID: 19217824
21. Duplantier AJ, van Hoek ML. The human cathelicidin antimicrobial peptide LL-37 as a potential treat-
ment for polymicrobial infected wounds. Front Immunol. 2013; 4: 1–14. https://doi.org/10.3389/fimmu.
2013.00001
22. Gro¨nberg A, Mahlapuu M, Ståhle M, Whately-Smith C, Rollman O. Treatment with LL-37 is safe and
effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clini-
cal trial. Wound Repair Regen. 2014; 22. https://doi.org/10.1111/wrr.12211 PMID: 25041740
23. Chen YH, Yang JT, Chau KH. Determination of the helix and beta form of proteins in aqueous solution
by circular dichroism. Biochemistry. 1974; 13: 3350–9. Available: http://www.ncbi.nlm.nih.gov/pubmed/
4366945 https://doi.org/10.1021/bi00713a027 PMID: 4366945
24. Seto GWJ, Marwaha S, Kobewka DM, Lewis RN a H, Separovic F, McElhaney RN. Interactions of the
Australian tree frog antimicrobial peptides aurein 1.2, citropin 1.1 and maculatin 1.1 with lipid model
membranes: differential scanning calorimetric and Fourier transform infrared spectroscopic studies.
Biochim Biophys Acta. 2007; 1768: 2787–800. https://doi.org/10.1016/j.bbamem.2007.07.018 PMID:
17825246
25. Barbosa EA, Iembo T, Martins GR, Silva LP, Prates MV, Andrade AC, et al. Skin secretion peptides: the
molecular facet of the deimatic behavior of the four-eyed frog, Physalaemus nattereri (Anura, Leptodac-
tylidae). Rapid Commun Mass Spectrom. 2015; 29: 2061–8. https://doi.org/10.1002/rcm.7313 PMID:
26443407
26. Conlon JM, Sonnevend A, Davidson C, David Smith D, Nielsen PF. The ascaphins: a family of antimi-
crobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei. Biochem Bio-
phys Res Commun. 2004; 320: 170–175. https://doi.org/10.1016/j.bbrc.2004.05.141 PMID: 15207717
27. Brand GD, Leite JRS a, Silva LP, Albuquerque S, Prates M V, Azevedo RB, et al. Dermaseptins from
Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxic-
ity to mammalian cells. J Biol Chem. 2002; 277: 49332–40. https://doi.org/10.1074/jbc.M209289200
PMID: 12379643
28. dos Santos RC, Ombredane AS, Souza JMT, Vasconcelos AG, Pla´cido A, Amorim A das GN, et al.
Lycopene-rich extract from red guava (Psidium guajava L.) displays cytotoxic effect against human
breast adenocarcinoma cell line MCF-7 via an apoptotic-like pathway. Food Res Int. 2017; https://doi.
org/10.1016/j.foodres.2017.10.045
29. Sato A, Omi T, Yamamoto A, Satake A, Hiramoto A, Masutani M, et al. MicroRNA-351 Regulates Two-
Types of Cell Death, Necrosis and Apoptosis, Induced by 5-fluoro-2’-deoxyuridine. PLoS One. Public
Library of Science; 2016; 11: e0153130. Available: https://doi.org/10.1371/journal.pone.0153130
PMID: 27071035
30. den Brok MH, Raaijmakers TK, Collado-Camps E, Adema GJ. Lipid Droplets as Immune Modulators in
Myeloid Cells. Trends Immunol. 2018; 39: 380–392. https://doi.org/10.1016/j.it.2018.01.012 PMID:
29478771
31. Wishart DS, Bigam CG, Holm A, Hodges RS, Sykes BD. 1H, 13C and 15N random coil NMR chemical
shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR. 1995; 5:
67–81. Available: http://www.ncbi.nlm.nih.gov/pubmed/7881273 PMID: 7881273
32. Påhlman LI, Mo¨rgelin M, Kasetty G, Olin AI, Schmidtchen A, Herwald H. Antimicrobial activity of fibrino-
gen and fibrinogen-derived peptides–a novel link between coagulation and innate immunity. Thromb
Intragenic antimicrobial peptides encrypted in human proteins
PLOS ONE | https://doi.org/10.1371/journal.pone.0220656 August 6, 2019 18 / 20
Haemost. Schattauer Publishers; 2013; 109: 930–939. https://doi.org/10.1160/TH12-10-0739 PMID:
23467586
33. Nilsson M, Wasylik S, Mo¨rgelin M, Olin AI, Meijers JCM, Derksen RHWM, et al. The antibacterial activity
of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from
Streptococcus pyogenes. Mol Microbiol. 2008; 67: 482–492. https://doi.org/10.1111/j.1365-2958.2007.
05974.x PMID: 18093092
34. Eisenberg D, Weiss RM, Terwilliger TC. The helical hydrophobic moment: a measure of the amphiphili-
city of a helix. Nature. 1982; 299: 371–4. Available: http://www.ncbi.nlm.nih.gov/pubmed/7110359
https://doi.org/10.1038/299371a0 PMID: 7110359
35. Zelezetsky I, Tossi A. Alpha-helical antimicrobial peptides—Using a sequence template to guide struc-
ture–activity relationship studies. Biochim Biophys Acta—Biomembr. Elsevier; 2006; 1758: 1436–1449.
https://doi.org/10.1016/J.BBAMEM.2006.03.021 PMID: 16678118
36. Iorga A, Dara L, Kaplowitz N. Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apo-
ptosis or Necrosis. Int J Mol Sci. 2017; 18: 1018. https://doi.org/10.3390/ijms18051018 PMID:
28486401
37. Giuliani A, Pirri G, Rinaldi AC. Antimicrobial Peptides: The LPS Connection. Methods in molecular biol-
ogy (Clifton, NJ). 2010. pp. 137–154. https://doi.org/10.1007/978-1-60761-594-1_10 PMID: 20094863
38. Li L-H, Ju T-C, Hsieh C-Y, Dong W-C, Chen W-T, Hua K-F, et al. A synthetic cationic antimicrobial pep-
tide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP.
Mukhopadhyay P, editor. PLoS One. Public Library of Science; 2017; 12: e0182057. https://doi.org/10.
1371/journal.pone.0182057 PMID: 28750089
39. Chan DI, Prenner EJ, Vogel HJ. Tryptophan- and arginine-rich antimicrobial peptides: Structures and
mechanisms of action. Biochim Biophys Acta—Biomembr. Elsevier; 2006; 1758: 1184–1202. https://
doi.org/10.1016/J.BBAMEM.2006.04.006 PMID: 16756942
40. Zhao G, London E. An amino acid “transmembrane tendency” scale that approaches the theoretical
limit to accuracy for prediction of transmembrane helices: relationship to biological hydrophobicity. Pro-
tein Sci. 2006; 15: 1987–2001. https://doi.org/10.1110/ps.062286306 PMID: 16877712
41. Conchillo-Sole´ O, de Groot NS, Avile´s FX, Vendrell J, Daura X, Ventura S. AGGRESCAN: a server for
the prediction and evaluation of “hot spots” of aggregation in polypeptides. BMC Bioinformatics. 2007;
8: 65. https://doi.org/10.1186/1471-2105-8-65 PMID: 17324296
42. Chan W, White P. Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University
Press; 2000.
43. Kirschenbaum DM. Molar absorptivity and A-1% 1cm values for proteins at selected wavelengths of the
ultraviolet and visible regions. X. Anal Biochem. 1975; 64: 186–213. Available: http://www.ncbi.nlm.nih.
gov/pubmed/237427 https://doi.org/10.1016/0003-2697(75)90420-0 PMID: 237427
44. Wadell WJ. A simple UV spectrophotometric method for the determination of protein. J Lab Clin Med.
1956; 48: 311–314. PMID: 13346201
45. Stewart JC. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Bio-
chem. 1980; 104: 10–4. Available: http://www.ncbi.nlm.nih.gov/pubmed/6892980 https://doi.org/10.
1016/0003-2697(80)90269-9 PMID: 6892980
46. CLSI. M07-A10: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobi-
cally; Approved Standard—Tenth Edition. 2015;35: 1–87.
47. CLSI. M27-A3: Reference method for broth dilution antifungal susceptibility testing of yeasts: approved
standard—Third Edition. 2008; 1–25.
48. CLSI. M38-A2: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous
Fungi; Approved Standard—Second Edition. Clin Lab Stand Inst. 2008;28: 29.
49. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 1983; 65: 55–63. Available: http://www.ncbi.nlm.nih.gov/
pubmed/6606682 https://doi.org/10.1016/0022-1759(83)90303-4 PMID: 6606682
50. Norris M, Fetler B, Marchant J, Johnson BA. NMRFx Processor: a cross-platform NMR data processing
program. J Biomol NMR. 2016; 65: 205–216. https://doi.org/10.1007/s10858-016-0049-6 PMID:
27457481
51. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, et al. The CCPN data model for
NMR spectroscopy: Development of a software pipeline. Proteins Struct Funct Bioinforma. 2005; 59:
687–696. https://doi.org/10.1002/prot.20449 PMID: 15815974
52. Wu¨thrich K. NMR of proteins and nucleic acids [Internet]. Available: https://www.wiley.com/en-us/NMR
+of+Proteins+and+Nucleic+Acids-p-9780471828938
Intragenic antimicrobial peptides encrypted in human proteins
PLOS ONE | https://doi.org/10.1371/journal.pone.0220656 August 6, 2019 19 / 20
53. Skinner SP, Goult BT, Fogh RH, Boucher W, Stevens TJ, Laue ED, et al. Structure calculation, refine-
ment and validation using CcpNmr Analysis. Acta Crystallogr Sect D Biol Crystallogr. 2015; 71: 154–
161. https://doi.org/10.1107/S1399004714026662 PMID: 25615869
54. Rieping W, Habeck M, Bardiaux B, Bernard A, Malliavin TE, Nilges M. ARIA2: automated NOE assign-
ment and data integration in NMR structure calculation. Bioinformatics. 2007; 23: 381–2. https://doi.org/
10.1093/bioinformatics/btl589 PMID: 17121777
55. Brunger AT. Version 1.2 of the Crystallography and NMR system. Nat Protoc. 2007; 2: 2728–2733.
https://doi.org/10.1038/nprot.2007.406 PMID: 18007608
Intragenic antimicrobial peptides encrypted in human proteins
PLOS ONE | https://doi.org/10.1371/journal.pone.0220656 August 6, 2019 20 / 20
